The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Neoadjuvant versus adjuvant treatment: Which one is better for resectable locally advanced esophageal squamous cell carcinoma?
Qixun Chen
No relevant relationships to disclose
Yaping Xu
No relevant relationships to disclose
Yuanda Zheng
No relevant relationships to disclose
Xinmin Yu
No relevant relationships to disclose
Qingren Lin
No relevant relationships to disclose
Youhua Jiang
No relevant relationships to disclose
Xinming Zhou
No relevant relationships to disclose
Weimin Mao
No relevant relationships to disclose